ABSTRACT
The first order of business for anyone involved in clinical research who wants to look at patient protections is to recognize the role past errors in our industry have played in creating public skepticism and mistrust of studies. Consider just a few examples:
The Tuskegee Syphilis Study by the US Public Health Service, conducted between 1932 and 1972, involved 600 African-American men who were misled about the nature of the study, were not given the opportunity to withdraw and were denied adequate treatment for their illness.1
